English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Journal article
Lau, George, Obi, Shuntaro, Zhou, Jian, Tateishi, Ryosuke, Qin, Shukui, Zhao, Haitao, Otsuka, Motoyuki, Ogasawara, Sadahisa, George, Jacob, Chow, Pierce K.H., Cai, Jianqiang, Shiina, Shuichiro, Kato, Naoya, Yokosuka, Osamu, Oura, Kyoko, Yau, Thomas, Chan, Stephen L., Kuang, Ming, Ueno, Yoshiyuki, Chen, Minshan, Cheng, Ann Lii, Cheng, Gregory, Chuang, Wan Long, Baatarkhuu, Oidov, Bi, Feng, Dan, Yock Young, Gani, Rino A., Tanaka, Atsushi, Jafri, Wasim, Jia, Ji Dong, Kao, Jia Horng, Hasegawa, Kiyoshi, Lau, Patrick, Lee, Jeong Min, Liang, Jun, Liu, Zhenwen, Lu, Yinying, Pan, Hongming, Payawal, Diana A., Rahman, Salimur, Seong, Jinsil, Shen, Feng, Shiha, Gamal, Song, Tianqiang, Sun, Hui Chuan, Masaki, Tsutomu, Sirachainan, Ekaphop, Wei, Lai, Yang, Jin Mo, Sallano, Jose D., Zhang, Yanqiao, Tanwandee, Tawesak, Dokmeci, AKadir, Zheng, Shu Sen, fan, Jia, Fan, Sheung Tat, Sarin, Shiv Kumar, Omata, Masao. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024[J]. Hepatology International, 2024, 18(6), 1661-1683.
Authors:  Lau, George;  Obi, Shuntaro;  Zhou, Jian;  Tateishi, Ryosuke;  Qin, Shukui; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:5.9/6.6 | Submit date：2024/12/05
Hepatocellular Carcinoma  Systemic Therapy  Guidelines  The Asian Pacific Association For The Study Of The Liver  
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment Journal article
Yang, Zhenyun, Wang, Xin, Fu, Yizhen, Wu, Weijie, Hu, Zili, Lin, Qingyang, Peng, Wei, Pan, Yangxun, Wang, Juncheng, Chen, Jinbin, Hu, Dandan, Zhou, Zhongguo, Xu, Li, Zhang, Yaojun, Hou, Jiajie, Chen, Minshan. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment[J]. Molecular Cancer, 2024, 23(1), 186.
Authors:  Yang, Zhenyun;  Wang, Xin;  Fu, Yizhen;  Wu, Weijie;  Hu, Zili; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:27.7/31.3 | Submit date：2024/10/10
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity Journal article
Zhang, Haiyan, Luo, Xiaojing, Yang, Wei, Wu, Zhiying, Zhao, Zhicong, Pei, Xin, Zhang, Xue, Chen, Chonghao, Lei, Josh Haipeng, Shi, Qingxia, Zhao, Qi, Chen, Yanxing, Wu, Wenwei, Zeng, Zhaolei, Ju, Huai Qiang, Qiu, Miaozhen, Liu, Jun, Shen, Bin, Chen, Minshan, Chen, Jianjun, Deng, Chu Xia, Xu, Rui Hua, Hou, Jiajie. YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity[J]. Nature Communications, 2024, 15(1), 9559.
Authors:  Zhang, Haiyan;  Luo, Xiaojing;  Yang, Wei;  Wu, Zhiying;  Zhao, Zhicong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:14.7/16.1 | Submit date：2024/12/05
Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19 Journal article
Chen, Liping, Shen, Lihan, Wu, Weichen, Guan, Wenda, Zhou, Jinchao, Luo, Gengyan, Chen, Qimin, Zhou, Hongxia, Deng, Zhenxuan, Chen, Yaoqing, Zhao, Wenjing, Jin, Wenxiang, Qiu, Minshan, Zheng, Qianwei, Wang, Yutao, Liu, Chen, Bai, Xiangxiang, Guo, Deyin, Holmes, Edward C., Zhong, Nanshan, Shi, Mang, Yang, Zifeng. Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19[J]. Journal of Thoracic Disease, 2022, 14(2), 355-370.
Authors:  Chen, Liping;  Shen, Lihan;  Wu, Weichen;  Guan, Wenda;  Zhou, Jinchao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:2.1/2.5 | Submit date：2023/01/30
Co-infection  Covid-19  Inflammatory Responses  Meta-transcriptomics  Total Infectome